DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo

InterMune (NASDAQ: ITMN)



company name or ticker
Company Photos
(Click to zoom)

Insider Trading Alert - ROSE, ITMN And MHFI Traded By Insiders

After Idenix: The Next Four Biotech Buyout Candidates

InterMune Resubmits Esbriet NDA - Analyst Blog

3 Stocks to Get on Your Watchlist

A biotech with a newly approved drug, a potentially cheap banking giant, and a possibly overvalued clinical-stage biotech with a promising rare-disease drug are this week's must-watch stocks.

Isis Shines, PTC Therapeutics Soars - Analyst Blog

The 3 Biggest Biotech Wins of the Week

See who released the best clinical results during the week ending May 25.

Sector Update: Healthcare Stocks Higher Pre-Market; Durata Sinks 11% After Strong Rally

Sector Update: Healthcare

5 Stocks Poised for Breakouts

This Week in Biotech: PTC Therapeutics Surprises, Isis' Data Dazzles, and Provectus Sinks

Four positive clinical updates, a billion-dollar licensing deal, a surprising positive opinion for one company in the EU, and a rough NYSEArca debut for one biopharma are this week's top biotech stories.
See More Articles...